ALPS Medical Breakthroughs ETF
SBIO
55 hedge funds and large institutions have $84.4M invested in ALPS Medical Breakthroughs ETF in 2018 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 23 increasing their positions, 8 reducing their positions, and 7 closing their positions.
188% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 8
143% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 7
30% more capital invested
Capital invested by funds: $65M → $84.4M (+$19.4M)
22% more funds holding
Funds holding: 45 → 55 (+10)
2% more call options, than puts
Call options by funds: $901K | Put options by funds: $884K
0.45% less ownership
Funds ownership: 29.8% → 29.35% (-0.45%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$4.56M |
| 2 |
Jane Street
New York
|
+$3.06M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.89M |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$1.93M |
| 5 |
CI
Cavalier Investments
Alpharetta,
Georgia
|
+$1.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Barometer Capital Management
Toronto,
Ontario, Canada
|
-$4.13M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$733K |
| 3 |
MCM
Murphy Capital Management
Bedminster,
New Jersey
|
-$37.9K |
| 4 |
CT
Cambridge Trust
Cambridge,
Massachusetts
|
-$29.6K |
| 5 |
BCA
Bay Colony Advisors
Concord,
Massachusetts
|
-$29K |
SBIO Hedge Fund Activity: Q3 2018 in Review
55 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q3 2018, worth a combined $84.4M — up 30% from $65M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new SBIO positions and 7 closed out — a net gain of 10 holders — while 23 added to existing stakes and 8 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $4.56M. The largest seller was Barometer Capital Management, cutting an estimated $4.13M.
- 55 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q3 2018, up from 45 in Q2 2018.
- Funds reported $84.4M of ALPS Medical Breakthroughs ETF stock for Q3 2018, up 30% quarter-over-quarter.
- 17 funds opened new ALPS Medical Breakthroughs ETF positions in Q3 2018 and 7 closed out, a net change of +10 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q3 2018 was Morgan Stanley, an estimated $4.56M added.
- The largest ALPS Medical Breakthroughs ETF seller in Q3 2018 was Barometer Capital Management, an estimated $4.13M sold.
Based on aggregated 13F filings for Q3 2018.